BIO REsponse Adapted Combination Therapy Pilot Study

NAUnknownINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

November 9, 2018

Primary Completion Date

January 3, 2022

Study Completion Date

March 31, 2024

Conditions
Peripheral Arterial Disease
Interventions
DIAGNOSTIC_TEST

Duplex Ultrasound (DUS)

Occurrence of a flow-limiting dissection or residual stenosis will be assessed by standard angiography and Duplex Ultrasound

DIAGNOSTIC_TEST

IVUS with Intraarterial pressure measurement (IAP) if needed

Occurrence of a flow-limiting dissection or residual stenosis will be assessed by standard angiography and Intra-vascular ultrasound associated to Intraarterial pressure measurement if needed

Trial Locations (15)

6000

Royal Perth Hospital, Perth

79189

Universitäts-Herzzentrum Freiburg • Bad Krozingen, Bad Krozingen

Unknown

Medical University Graz, Graz

Medizinische Universität Wien, Vienna

OLV Ziekenhuis, Aalst

A.Z. Sint-Blasius, Dendermonde

AZ Groeninge, Kortrijk

CHU de Nantes, Nantes

Hopital Paris Saint Joseph, Paris

Karolinen-Hospital, Klinikum Arnsberg, Arnsberg

SRH Klinikum Karlsbad-Langensteinbach, Biederbach Baden-Wurttemberg

Universitätsklinikum Leipzig, Leipzig

Universitätsklinikum, Tübingen

GRN Hospital, Weinheim

Hospital General de Guadalajara, Guadalajara

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biotronik AG

INDUSTRY

NCT03547986 - BIO REsponse Adapted Combination Therapy Pilot Study | Biotech Hunter | Biotech Hunter